Physician profile
Aleja Armenta
NPI 1306557137
$1,419.62
in general payments reported to CMS, 2019-2025
7 companies · $56.44 in 2025
The $56.44 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,363 · 2025: $56.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $777 · Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $776.60 |
| Food and Beverage | $643.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $972.86 | 2024 | Mako |
| Medical Device Business Services, INC. | $197.65 | 2024 | Ethicon, Stratafix |
| Endo USA, INC. | $135.58 | 2024 | Xiaflex |
| Heron Therapeutics, INC. | $57.09 | 2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $24.71 | 2025 | |
| Molnlycke Health Care US, LLC | $17.88 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Ferring Pharmaceuticals INC. | $13.85 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleja Armenta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.